Innovative device enhances nucleic acid extraction in clinical samples, indicating potential for improved diagnostics.
In point-of-care (POC) molecular diagnostics, inhibitors from liquid residue in a microfluidic chip fundamentally limit the performance of automated nucleic acid extraction (NAE). In response to this challenge, a multifaceted strategy has been developed. We engineered a novel U-shaped microchannel via injection molding, which inherently reduces liquid retention by 2-fold over conventional square channels. Critically, we identified that surfactants, while essential for lysis, were a major source of undesired liquid retention; a simple water-rinse stage was developed to counteract this effect, further decreasing the residue by 5-fold. Process efficiency was radically enhanced by integrating ultrasonic excitation, achieving both a sample-to-pure-NA time of just 5 min and NA recovery rates in microchips comparable to conventional extraction methods. These physical, chemical, and process-level innovations were consolidated into the universal automated nucleic acid extraction (UNEX) system. Featuring lyophilized, shelf-stable reagents for cold-chain independence, the UNEX system is a truly automated, sample-in-to-result-out platform. When benchmarked against traditional methods using various clinical samples, UNEX exhibited exceptional precision (CV < 2%) and quantitative accuracy (R² > 0.99). Our work provides a robust, field-deployable NAE solution, proving that a holistic approach (combining optimized channel geometry with intelligent fluidic protocols and energy-assisted elution) is key to unlocking the full potential of LOC technology in diagnostics.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: